title: Transfusion-Associated HIV Infection in Pediatric Leukemia Patients (Two Case Reports).
abstract: BACKGROUND
  Leukemia is the second most malignant tumor in children. The chemotherapy induced anemia (CIA) and hemorrhage are the most popular side-effects due to the myelosuppression of chemotherapy. So far, multitransfusion is still the timely and effective measure in curing these complications. The acquisition of HIV infection and subsequent development of AIDS by component transfusion from donors at risk is well known, and prognosis of HIV infection is particularly severe in patients with leukemia.
  
  
  METHODS
  We report two leukemic cases that were infected with HIV through transfusion. The first patient was totally transfused with 16 U RBC, 20 U platelets and 820 ml fresh frozen plasma, and later test showed that his first used FFP carried the HIV. For the second 2 U RBC, 5 U platelets and 1500 ml fresh frozen plasma were transfused to her. Late test of her used blood products showed that the fourth RBC carried the HIV. Both results were confirmed by the local Center for Disease Control (CDC). They were not transfused before the diagnosis of leukemia. Their parents were healthy with negative HIV-Ab.
  
  
  CONCLUSIONS
  Since the two leukemic patients suffered transfusion-associated HIV with poor prognosis, we must take more efforts to utilize blood products judiciously, manage blood donors, test blood samples etiologically, shorten HIV testing "window periods" and develop preventive vaccination against HIV to reduce the incidence as low as possible.
authors: Division of Clinical Laboratory, Children's Hospital, Zhejiang University School of Medicine, Zhejiang, China.
authors: Xuejun
authors: X
authors: Chen
authors: Mingming
authors: M
authors: Zhou
authors: Botao
authors: B
authors: Ning
authors: Hua
authors: H
authors: Song
authors: Shilong
authors: S
authors: Yang
authors: Yongmin
authors: Y
authors: Tang
keywords: AIDS; Blood Treansfusion; HIV; Leukemia
references: Med Oncol. 2000 Nov;17 Suppl 1:S2-10
references: 11188782
references: N Engl J Med. 1995 Dec 28;333(26):1721-5
references: 7491134
references: Curr Pharm Des. 2002;8(5):369-77
references: 12069375
references: Cell Res. 2005 Nov-Dec;15(11-12):825-32
references: 16354555
references: Oncologist. 2001;6(5):446-50
references: 11675523
references: Arch Fr Pediatr. 1989 Aug-Sep;46(7):499-502
references: 2596949
references: Natl Med J India. 2010 May-Jun;23(3):147-9
references: 20949716
references: BMJ. 2005 Jun 4;330(7503):1282-3
references: 15933339
references: Chin Med J (Engl). 2008 Jul 5;121(13):1230-6
references: 18710645
references: AIDS. 2010 Oct;24 Suppl 4:S50-60
references: 21042053
references: Vox Sang. 2010 Oct;99(3):239-50
references: 20576024
references: Trends Mol Med. 2002 Jul;8(7):355-8
references: 12114117
references: Nihon Rinsho. 2009 Oct;67(10):1951-7
references: 19860196
references: AIDS. 2007 Dec;21 Suppl 8:S33-8
references: 18172389
references: Nephrologie. 2002;23(1):19-22
references: 11887573
references: Pediatr Crit Care Med. 2011 Sep;12(5):512-8
references: 21057356
references: Blood. 2002 Nov 15;100(10):3457-69
references: 12411315
references: Leukemia. 2000 Mar;14(3):505-8
references: 10720151
references: AIDS. 2010 Jan 2;24(1):115-22
references: 19926963
references: Lancet. 1983 Apr 30;1(8331):956-8
references: 6132270
references: Vulnerable Child Youth Stud. 2008 Dec 1;3(3):192-202
references: 19960110
references: Pathophysiol Haemost Thromb. 2002;32 Suppl 1:1-4
references: 12214137